CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Biotechnologies Ltd., a foreign private issuer, on August 23, 2019. The report covers corporate governance events occurring during the month of August 2019.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report of a specific corporate event and does not contain financial statements.
Material Changes
The primary material change disclosed is the resignation of Jonathan Rigby as a member of the Board of Directors, effective immediately on August 23, 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the notification of the board member's resignation.
Key Facts for Investor Verification
- Jonathan Rigby resigned from the Board of Directors effective August 23, 2019.
- The report was signed by Eran Rotem, Deputy CEO and Chief Financial Officer.
- This filing is incorporated by reference into the company's Registration Statements on Form S-8 and Form F-3.